155 related articles for article (PubMed ID: 9582339)
1. Identification of a novel p53 functional domain that is necessary for mediating apoptosis.
Zhu J; Zhou W; Jiang J; Chen X
J Biol Chem; 1998 May; 273(21):13030-6. PubMed ID: 9582339
[TBL] [Abstract][Full Text] [Related]
2. Definition of the p53 functional domains necessary for inducing apoptosis.
Zhu J; Zhang S; Jiang J; Chen X
J Biol Chem; 2000 Dec; 275(51):39927-34. PubMed ID: 10982799
[TBL] [Abstract][Full Text] [Related]
3. A transcriptional activation function of p53 is dispensable for and inhibitory of its apoptotic function.
Kokontis JM; Wagner AJ; O'Leary M; Liao S; Hay N
Oncogene; 2001 Feb; 20(6):659-68. PubMed ID: 11313999
[TBL] [Abstract][Full Text] [Related]
4. Differential regulation of cellular target genes by p53 devoid of the PXXP motifs with impaired apoptotic activity.
Zhu J; Jiang J; Zhou W; Zhu K; Chen X
Oncogene; 1999 Mar; 18(12):2149-55. PubMed ID: 10321740
[TBL] [Abstract][Full Text] [Related]
5. The requirement for the p53 proline-rich functional domain for mediation of apoptosis is correlated with specific PIG3 gene transactivation and with transcriptional repression.
Venot C; Maratrat M; Dureuil C; Conseiller E; Bracco L; Debussche L
EMBO J; 1998 Aug; 17(16):4668-79. PubMed ID: 9707426
[TBL] [Abstract][Full Text] [Related]
6. p53 requires an intact C-terminal domain for DNA binding and transactivation.
Kim H; Kim K; Choi J; Heo K; Baek HJ; Roeder RG; An W
J Mol Biol; 2012 Feb; 415(5):843-54. PubMed ID: 22178617
[TBL] [Abstract][Full Text] [Related]
7. Identification of a novel p53 functional domain that is necessary for efficient growth suppression.
Walker KK; Levine AJ
Proc Natl Acad Sci U S A; 1996 Dec; 93(26):15335-40. PubMed ID: 8986812
[TBL] [Abstract][Full Text] [Related]
8. The C terminus of p53 family proteins is a cell fate determinant.
Harms KL; Chen X
Mol Cell Biol; 2005 Mar; 25(5):2014-30. PubMed ID: 15713654
[TBL] [Abstract][Full Text] [Related]
9. Tumor-derived mutations within the DNA-binding domain of p53 that phenotypically resemble the deletion of the proline-rich domain.
Roth J; Koch P; Contente A; Dobbelstein M
Oncogene; 2000 Mar; 19(14):1834-42. PubMed ID: 10777217
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of differential activation of target gene promoters by p53 hinge domain mutants with impaired apoptotic function.
Kong XT; Gao H; Stanbridge EJ
J Biol Chem; 2001 Aug; 276(35):32990-3000. PubMed ID: 11395510
[TBL] [Abstract][Full Text] [Related]
11. Biological significance of a small highly conserved region in the N terminus of the p53 tumour suppressor protein.
Liu WL; Midgley C; Stephen C; Saville M; Lane DP
J Mol Biol; 2001 Nov; 313(4):711-31. PubMed ID: 11697899
[TBL] [Abstract][Full Text] [Related]
12. p21/CDKN1A mediates negative regulation of transcription by p53.
Löhr K; Möritz C; Contente A; Dobbelstein M
J Biol Chem; 2003 Aug; 278(35):32507-16. PubMed ID: 12748190
[TBL] [Abstract][Full Text] [Related]
13. Regulation of transcription functions of the p53 tumor suppressor by the mdm-2 oncogene.
Chen J; Lin J; Levine AJ
Mol Med; 1995 Jan; 1(2):142-52. PubMed ID: 8529093
[TBL] [Abstract][Full Text] [Related]
14. p53 basic C terminus regulates p53 functions through DNA binding modulation of subset of target genes.
Hamard PJ; Lukin DJ; Manfredi JJ
J Biol Chem; 2012 Jun; 287(26):22397-407. PubMed ID: 22514277
[TBL] [Abstract][Full Text] [Related]
15. Activation of p53 DNA binding activity by point mutation.
Marston NJ; Ludwig RL; Vousden KH
Oncogene; 1998 Jun; 16(24):3123-31. PubMed ID: 9671391
[TBL] [Abstract][Full Text] [Related]
16. p53 mediated apoptosis in HeLa cells: transcription dependent and independent mechanisms.
Haupt Y; Rowan S; Shaulian E; Kazaz A; Vousden K; Oren M
Leukemia; 1997 Apr; 11 Suppl 3():337-9. PubMed ID: 9209383
[TBL] [Abstract][Full Text] [Related]
17. Mutational analysis of the p53 core domain L1 loop.
Zupnick A; Prives C
J Biol Chem; 2006 Jul; 281(29):20464-73. PubMed ID: 16687402
[TBL] [Abstract][Full Text] [Related]
18. Modulation of p53 activity by IkappaBalpha: evidence suggesting a common phylogeny between NF-kappaB and p53 transcription factors.
Dreyfus DH; Nagasawa M; Gelfand EW; Ghoda LY
BMC Immunol; 2005 Jun; 6():12. PubMed ID: 15969767
[TBL] [Abstract][Full Text] [Related]
19. N-terminal 130 amino acids of MDM2 are sufficient to inhibit p53-mediated transcriptional activation.
Leng P; Brown DR; Shivakumar CV; Deb S; Deb SP
Oncogene; 1995 Apr; 10(7):1275-82. PubMed ID: 7731677
[TBL] [Abstract][Full Text] [Related]
20. Loss of transactivation and transrepression function, and not RPA binding, alters growth suppression by p53.
Leiter LM; Chen J; Marathe T; Tanaka M; Dutta A
Oncogene; 1996 Jun; 12(12):2661-8. PubMed ID: 8700525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
